Lung Transplant Week

HomePatientsLung Disease Week at the ATS2015 ▶ Lung Transplant Week
Lung Transplant Week

Lung Transplant Week

Welcome Message

It is with great pleasure that we welcome you to “Lung Transplant Week at the ATS”,  a  joint effort of the American Thoracic Society (ATS) and the Lung Transplant Foundation (LTF).
Our goal is to provide information that may be helpful to you in the context of your overall medical care for your chronic lung disease.

The decision as to whether to consider lung transplantation is complex and depends on many factors, including the nature, severity and progression of peoples’ underlying lung disease, their co-morbid medical and psychological health conditions, the medical treatments available for the underlying lung disease and patients’ responses to this therapy, individuals’ desire and commitment to pursue lung transplantation, their social support network, and the likelihood that undergoing lung transplantation will improve their health and survival. It is very important for people who may be candidates for transplantation to discuss this issue thoroughly with their healthcare providers and family members, to enable careful consideration of the “pros” and “cons” and to thoroughly weigh all treatment options for the lung condition.

Further general information regarding lung transplantation is provided on the following pages. The major factor that currently limits lung transplantation is the number of available donor lungs. Intensive research is underway in effort to improve the availability of donor lungs as well as to reduce complications and improve outcomes of lung transplantation. The ATS and LTF support those who are working diligently to develop strategies that will improve the lives of lung transplant recipients.


Carolyn Rochester, MD

Carolyn Rochester, MD
Associate Professor of Medicine; Medical Director, Pulmonary Rehabilitation Program;
Medical Director, Yale COPD Center
Member, ATS Board of Directors

Jeff Goldstein

Jeff Goldstein
President, Lung Transplant Foundation
Member, ATS Public Advisory Roundtable




In June 2009, the national Lung Transplant Foundation (LTF) was founded as a non-profit organization by a group of lung transplant recipients from Durham and Chapel Hill, NC. These recipients from Duke University and UNC Hospitals realized promotion and funding of research to improve the post lung transplant experience and long term outcomes was severely lacking, so they created the LTF to tackle one of the most difficult and life-threatening issues facing transplant recipients, chronic rejection or bronchiolitis obliterans syndrome (BOS).